Clinical Drug Development
A freestanding university course worth 30 credits
The course and its administration are organised by the Department of Medical Sciences at Uppsala University, but since autumn 2010 the course has been run in collaboration with UCR.
Aim
The 30-credit course Clinical Drug Development aims to provide a broad and in-depth understanding of drug development, with a focus on ethical considerations, scientific principles and methodology.
Course Concent
During the course, students gain knowledge of the applicable regulatory framework as well as insight into several specialist areas. Theory is combined with practical components to prepare students for their future professional roles.
At the end of the course, all students design a clinical study and write a complete study protocol, applying the knowledge they have gained throughout the semester.
Additional information
The course is taught in English.
The course director is Håkan Melhus. The assistant course director is Anna Gustavsson, anna.gustavsson@ucr.uu.se, and the course administrator is Kristin Bryon, kristin.bryon@medsci.uu.se.
The course is offered every autumn semester. Applications are submitted through Uppsala University and the national admissions system.
The course was established in 1995 on the initiative of the then Pharmacia and has been offered every year since. More than 600 students have completed the course and gone on to careers in roles such as clinical trial managers, monitors, medical writers, regulatory affairs professionals, pharmaceutical representatives and safety officers.